Soochow University, Suzhou 215000, Jiangsu Province, China; Department of Orthopaedic Surgery, Children's Hospital of Soochow University, China.
Graduate School of Molecular Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York.
J Plast Reconstr Aesthet Surg. 2022 Nov;75(11):4054-4062. doi: 10.1016/j.bjps.2022.06.059. Epub 2022 Jul 27.
Macrodactyly is a very rare congenital difference that affects hands and feet with significant developmental and psychological implications. Macrodactyly is attributed to a somatic mutation in PIK3CA, a component of the mTOR pathway-related overgrowth disorders. Other medical conditions have been associated with macrodactyly (e.g., neurofibromatosis and Proteus syndrome). A thorough investigation of the presence of these conditions should be undertaken by the multidisciplinary team. The aim of this study is to summarize the main clinical characteristics and associated conditions, with an emphasis on diagnosis and surgical treatment options.
We present several clinical cases after a retrospective chart review of macrodactyly cases and a comprehensive literature review.
The indications for surgery include peripheral compressive neuropathies (e.g., carpal tunnel syndrome), grotesque enlargement interfering with function, psychosocial distress due to the deformity, and macrodystrophic lipomatosis with proximal upper limb involvement. The main surgical treatment options are categorized as follows: digit reduction (e.g., soft tissue debulking, skeletal shortening/ terminalization, Barsky procedure, and Tsuge technique), limitation of growth (digital nerve stripping and epiphysiodesis), and correction of deviation (wedge or angulation osteotomy, arthrodesis, Millesi procedure for thumb macrodactyly correction, toe-to-hand transfer, ray resection, and combination of bony reduction and soft tissue debulking).
Macrodactyly correction requires surgical experience and an individualized approach. Treatment is primarily surgical; however, efforts are being made to delineate the root cause of macrodactyly and provide nonoperative management.
巨指症是一种非常罕见的先天性差异,影响手和脚,具有重大的发育和心理影响。巨指症归因于 PIK3CA 的体细胞突变,PIK3CA 是 mTOR 通路相关过度生长障碍的组成部分。其他医疗状况也与巨指症有关(例如,神经纤维瘤病和 Proteus 综合征)。多学科团队应彻底调查这些疾病的存在。本研究旨在总结主要的临床特征和相关疾病,重点是诊断和手术治疗选择。
我们回顾性地回顾了巨指症病例的图表,并进行了全面的文献复习,介绍了几个临床病例。
手术指征包括周围压迫性神经病(例如腕管综合征)、畸形导致的怪异增大影响功能、因畸形导致的心理社会困扰,以及近端上肢受累的巨脂血症。主要的手术治疗选择如下分类:指节缩小(例如软组织去脂、骨骼缩短/终末化、Barsky 手术和 Tsuge 技术)、生长限制(数字神经剥离和骺板切除术)以及矫正偏差(楔形或成角截骨术、关节融合术、拇指巨指症矫正的 Millesi 手术、足趾到手转移、射线切除术以及骨减少和软组织去脂的联合)。
巨指症的矫正需要手术经验和个体化方法。治疗主要是手术,但正在努力阐明巨指症的根本原因并提供非手术治疗。